Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

The CITIID-NIHR BioResource COVID-19 Collaboration, The COVID-19 Genomics UK (COG-UK) Consortium, Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, Bo Meng, Rawlings Datir, Alexandra C. Walls, Steven A. Kemp S, Jessica Bassi, Dora Pinto, Chiara Silacci Fregni, Siro Bianchi, M. Alejandra Tortorici, John Bowen, Katja Culap, Stefano Jaconi, Elisabetta Cameroni, Gyorgy Snell, Matteo S. PizzutoAlessandra Franzetti Pellanda, Christian Garzoni, Agostino Riva, Anne Elmer, Nathalie Kingston, Barbara Graves, Laura E. McCoy, Kenneth G. C. Smith, John R. Bradley, Nigel Temperton, L. Lourdes Ceron-Gutierrez, Gabriela Barcenas-Morales, William Harvey, Herbert W. Virgin, Antonio Lanzavecchia, Luca Piccoli, Rainer Doffinger, Mark Wills, David Veesler, Davide Corti*, Ravindra K. Gupta*, Matthew Bashton, Greg Young, Clare McCann, Andrew Nelson, Darren Smith

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

367 Citations (Scopus)
6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology